Pune: Over two months after the first Guillain-Barré syndrome (GBS) cases were reported in the city, the civic body has ...

says official In a major relief for patients diagnosed with Guillain-Barré Syndrome (GBS), the Pune Municipal Corporation (PMC) has extended its financial assistance for the affected until March 31.

Following a decline in GBS cases, PMC has written to the state public health department on Thursday to declare end of the ...

Current treatments for GBS are limited and often inadequate, with many patients experiencing long-term effects. Researchers are developing new therapies that specifically target GBS, offering hope ...

Chhatrapati Sambhajinagar: A 14-year-old boy, Yash Nitin Hiwrale, succumbed to Guillain-Barré Syndrome (GBS) at a private ...

District health authorities on Thursday reported the death of a 14-year-old boy from Guillain-Barre Syndrome (GBS), taking the countrywide toll in the recent outbreak of the rare neurological disease ...

Arcellx's innovative cell therapy platform shows promising potential in treating multiple myeloma, a significant unmet ...

Five years ago the country's first national lockdown began. Now, as Ebola, Mpox and bird flu are deemed 'high risk', experts ...

Kadence Holthouser couldn't walk, talk or breathe on her own. Paralyzed from the head down. Four months later, she was back ...

Kadence Holthouser couldn't walk, talk or breathe on her own. Paralyzed from the head down. Four months later, she was back ...

022). This interesting study suggests that patients whose IgG levels increase less after treatment of GBS with IVIg have worse outcomes compared with those who have larger increases in IgG.

Hansa Biopharma AB, "Hansa" or the "Company" , today published its Annual and Sustainability Reports for 2024. Peter Nicklin, Chair of the Board, Hansa Biopharma, said: "Hansa delivered several ...